Baxter to divest Vantive Kidney Care segment to Carlyle for $3.8bn
Medtech Baxter International and funds managed by global investment firm Carlyle have signed a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion. Baxter announced its intention to …